Pharmaceutical & Biotech

Brazil Plans to Produce Oxford's COVID-19 Vaccine, an Industrial Info Market Brief

Oxford's COVID-19 vaccine human trials in Sao Paulo, Brazil are underway, and after an agreement with AstraZeneca, the government of Brazil is planning to acquire the first vaccine batches.

Released Thursday, July 30, 2020

Loading…

Reports related to this article:

Oxford's COVID-19 vaccine human trials in Sao Paulo, Brazil, are underway, and after an agreement with AstraZeneca, the government of Brazil is planning to acquire the first vaccine batches. Vaccine production will begin at the end of 2020 and the beginning of 2021. The total investment is $127 million, and it will be developed through Brazil's national pharmaceutical company, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos.

/iirenergy/industry-news/article.jsp false

Share This Article

Want More IIR News Intelligence?

Make us a Preferred Source on Google to see more of us when you search.

Add Us On Google

Please verify you are not a bot to enable forms.

What is 69 + 1?

Ask Us

Have a question for our staff?

Submit a question and one of our experts will be happy to assist you.

By submitting this form, you give Industrial Info permission to contact you by email in response to your inquiry.

A glowing computer chip is placed on a dark blue circuit board. Bright blue lines and nodes create a futuristic, technological ambiance.

Explore Our EnergyLive Tools

EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.

Explore Our Tools
Dimly lit data center with rows of towering black server racks, glowing blue lights, and a sleek, futuristic ambiance.

Explore Our Enery Industry Reports

Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.

View Reports

Get notifications from IIR News Intelligence

Click 'Sign Up' then 'Allow'